Elsevier

Neuroscience Letters

Volume 387, Issue 1, 14 October 2005, Pages 11-16
Neuroscience Letters

Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese

https://doi.org/10.1016/j.neulet.2005.07.009Get rights and content

Abstract

A functional polymorphism in the coding region of brain-derived neurotrophic factor (BDNF) gene (196 A/G, Met66Val) has recently been reported to be associated with Alzheimer's disease (AD) and with an overrepresentation of G allele in AD patients, but different results have also been presented. We conducted a case–control study to analyze the association between the BDNF A/G polymorphism and sporadic AD in a sample composed of 203 AD patients and 239 controls from Mainland Chinese Han population. No association between the polymorphism and AD, no association between the polymorphism and age at onset in AD, and no significant interaction between BDNF and apolipoprotein E (APOE) genotype were detected in either the total or the male samples. However, a significantly high frequency of the GG genotype in the female controls compared with the female patients was detected. A postponed age at onset in the female patients with the GG genotype was also observed. These results suggest that the GG genotype has a protection effect from AD development in females. A significant low frequency of AD patients with the BDNF GG genotype in the AD APOEɛ4 carriers compared with the frequency of the controls with the BDNF GG genotype in the control APOEɛ4 carriers was also detected in the female individuals, suggesting that the BDNF GG genotype may reduce the effect of APOEɛ4 on AD risk in females. Additionally, low frequencies of BDNF G allele and GG genotype were revealed in Chinese when compared with that in the other race populations so far reported.

Section snippets

Acknowledgement

This study was supported by grant 99-699 from the China Medical Board of New York.

References (25)

  • O. Combarros et al.

    Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease

    Dement. Geriatr. Cogn. Disord.

    (2004)
  • M. Fahnestock et al.

    Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule

    J. Neural. Transm. Suppl.

    (2002)
  • Cited by (44)

    • Association between the Val66Met polymorphism (rs6265/G196A) of the BDNF gene and cognitive performance with SSRI use in Arab Alzheimer's disease patients

      2021, Saudi Pharmaceutical Journal
      Citation Excerpt :

      Therefore, individuals with the A allele (Met) can expect to show clinically significant memory impairment within 3 years, whereas BDNF G allele (Val) individuals did not show a similar degree of impairment until 10 years later (Lim et al., 2015). Additionally, research findings broadly support the work of other studies in this area linking the BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia (Bian et al., 2005). Regarding the association of age and allele distribution, there were no significant associations with aging changes.

    • Female-specific effect of the BDNF gene on Alzheimer's disease

      2017, Neurobiology of Aging
      Citation Excerpt :

      As a result, a total of 26,958 AD cases and 46,941 controls were analyzed (Supplementary Table S2) (Akatsu et al., 2006; Bagnoli et al., 2004; Bian et al., 2005; Bodner et al., 2005; Boiocchi et al., 2013; Borroni et al., 2012; Combarros et al., 2004; Cozza et al., 2008; Desai et al., 2005; Feher et al., 2009; Forero et al., 2006; Fukumoto et al., 2010; Giedraitis et al., 2009; He et al., 2007; Huang et al., 2007; Lambert et al., 2013; Lee et al., 2005; Li et al., 2005, 2008; Matsushita et al., 2005; Nishimura et al., 2005; Pivac et al., 2011; Reiman et al., 2007; Saarela et al., 2006; Sonali et al., 2013; Tsai et al., 2006; Ventriglia et al., 2002; Vepsalainen et al., 2005; Vieira et al., 2015; Yu et al., 2008; Zhang et al., 2006). For gender-specific analysis, 3737 AD cases and 3744 controls for females and 2101 AD cases and 2477 controls for males from 16 previous studies with gender information (Akatsu et al., 2006; Bian et al., 2005; Boiocchi et al., 2013; Combarros et al., 2004; Desai et al., 2005; Forero et al., 2006; Fukumoto et al., 2010; He et al., 2007; Lee et al., 2005; Li et al., 2005; Matsushita et al., 2005; Nishimura et al., 2005; Pivac et al., 2011; Saarela et al., 2006; Tsai et al., 2006; Yu et al., 2008) and the current Han Chinese data were considered (Supplementary Table S3). Meta-analysis was performed using the STATA version 13 (Stata Corporation, College Station, TX, USA) under the random-effect model if there was a significant heterogeneity (I2 >50%) or under the fixed-effect model when I2 <50%.

    • Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease

      2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    View all citing articles on Scopus
    View full text